Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao Ying He Ji (消瘿合剂) is a traditional Chinese medicine (TCM) compound formulation primarily used for the treatment of thyroid-related disorders, especially autoimmune thyroid diseases such as Hashimoto's thyroiditis and hypothyroidism. The formula typically contains herbs like Prunella vulgaris (夏枯草), Sinapis alba (白芥子), Astragalus membranaceus (黄芪), and Paeonia lactiflora (白芍), among others. Its therapeutic actions include resolving phlegm and dissipating nodules, tonifying qi and nourishing yin, regulating immune function, reducing autoantibody levels in patients with Hashimoto's thyroiditis, improving clinical symptoms of hypothyroidism-induced hypogonadism, and modulating the Treg/Th17 cell axis. Clinical studies have shown that Xiao Ying He Ji can improve both thyroid hormone levels and sex hormone profiles in affected patients with minimal adverse effects[1][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiao ying he ji.